Severe Hypophosphatemia as the Initial Presentation of Renal Fanconi’s Syndrome and Distal Renal Tubular Acidosis Related to Zoledronic Acid: A Case Report and Literature Review
Kidney and Blood Pressure Research · 2023 · 48 (1) · 18-27
DOI: 10.1159/000527931 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Kidney and Blood Pressure Research, online erschienen am 21.11.2022. Verfasst von Yujia Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Acidosis, Renal Tubular, Hypophosphatemia, Fanconi Syndrome, Acute Kidney Injury. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Zoledronic acid (ZA) is a widely used bisphosphonate compound for the prevention of skeletal metastasis-associated osteolysis and treatment of post-menopause osteoporosis. Acute kidney injury is one of the commonly described renal complications. Electrolyte disorder has also been reported relevant to ZA exposure and nephrotoxicity. Syndrome of persistent hypophosphatemia, hypokalemia, and metabolic acidosis is regarded as the initial signs of acute kidney injury. Case Presentation: We reported a 64-year-old female with bone metastasis from lung adenocarcinoma who received a 5-year history of 4-week cycle of ZA infusion. She initially presented with symptomatic severe hypophosphatemia and was finally identified with ZA-induced generalized tubular dysfunction as Fanconi’s syndrome and distal renal tubular acidosis. Renal pathological findings revealed toxic renal tubular necrosis. The ZA infusion was thus extended to an 8-week cycle with oral phosphate supplementation and alfacalcidol. Although periodic changes pre- and post-ZA infusion existed yet, hypophosphatemia was effectively improved, and the rapid decline of eGFR was partially delayed. We reviewed the literature and mainly summarized the characteristics of bisphosphonate-associated hypophosphatemia. Moderate hypophosphatemia was more frequently mentioned in contrast to severe cases being predisposed to be reported. Progressive hypophosphatemia serves as an early sign of kidney injury.
Conclusion
Progressive electrolyte disorders and CKD were the long-term renal outcomes of the current patient. We would like to arouse more attention to electrolyte imbalance related to early ZA-induced kidney injury and emphasize the significance of close monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
- Renal Pathology Center, Institute of Nephrology, Peking University, Beijing, China.
- Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
Zitieren
APA
Wu, Y., Ma, T., Yu, X., & Su, T. (2023). Severe Hypophosphatemia as the Initial Presentation of Renal Fanconi’s Syndrome and Distal Renal Tubular Acidosis Related to Zoledronic Acid: A Case Report and Literature Review. Kidney and Blood Pressure Research, 48(1), 18-27. https://doi.org/10.1159/000527931
Vancouver
Wu Y, Ma T, Yu X, Su T. Severe Hypophosphatemia as the Initial Presentation of Renal Fanconi’s Syndrome and Distal Renal Tubular Acidosis Related to Zoledronic Acid: A Case Report and Literature Review. Kidney and Blood Pressure Research. 2023;48(1):18-27. doi:10.1159/000527931
BibTeX
@article{Wu2023,
author = {Wu, Yujia and Ma, Tiantian and Yu, Xiaojuan and Su, Tao},
title = {Severe Hypophosphatemia as the Initial Presentation of Renal Fanconi’s Syndrome and Distal Renal Tubular Acidosis Related to Zoledronic Acid: A Case Report and Literature Review},
journal = {Kidney and Blood Pressure Research},
year = {2023},
volume = {48},
number = {1},
pages = {18--27},
doi = {10.1159/000527931}
}
EUVIMED